IN8bio, Inc. (INAB) stock
INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.82−0.00 (-0.04%)
Close on Nov 13, 2026Market cap $8.08MP/E –Yield –
IN8bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
IN8bio's enterprise value was -$9.37M on Nov 11, 2026, against -$1.60M a year earlier. Over the last 5 years it ranged from -$12.74M to $65.03M, with a median of $11.00M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$9.37M | -18939.9% |
| 2025 | Dec 31, 2025 | $49.72K | -99.4% |
| 2024 | Dec 31, 2024 | $8.03M | -74.3% |
| 2023 | Dec 29, 2023 | $31.28M | +8.0% |
| 2022 | Dec 30, 2022 | $28.96M | -30.9% |
| 2021 | Dec 31, 2021 | $41.92M | – |
See a number that looks wrong?